Literature DB >> 20373056

Clinical stage of lung cancer revised by accidental pneumothorax and positron emission tomography.

Qingliang Xue1, Junping Sun, Lina Guo, Jianxin Wang.   

Abstract

Clinical lung cancer staging is an important basis for choosing treatment modalities and prognosing outcomes. However, it is not always accurate. We reported an interesting process of clinically staging in a case with lung cancer. According to admission computer tomography findings, he was preliminarily diagnosed as stage IV with nonprimary-tumor lobe metastasis and chest wall invasion. Computer tomography findings after accidental pneumothorax resulting from percutaneous puncture biopsy and positron emission tomography findings denied the chest wall invasion and nonprimary-tumor lobe metastasis. His diagnosis was revised as stage IIa that was confirmed subsequently by histological staging after surgery and follow-up. Our experiences indicate computer tomography scanning after artificial pneumothorax is a useful tool for identifying whether or not chest wall is invaded directly by an adjacent tumor, and positron emission tomography scanning needs to be considered for accurately evaluating the nature of concurrent pulmonary nodules in patients with lung cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20373056     DOI: 10.1007/s12032-010-9513-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  11 in total

Review 1.  Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Momen M Wahidi; Joseph A Govert; Ranjit K Goudar; Michael K Gould; Douglas C McCrory
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

2.  Tumor invasion of the chest wall and mediastinum in lung cancer: evaluation with pneumothorax CT.

Authors:  K Yokoi; K Mori; N Miyazawa; Y Saito; A Okuyama; M Sasagawa
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

Review 3.  Surgery for non-small cell lung cancer--new trends.

Authors:  D A Waller
Journal:  Lung Cancer       Date:  2001-12       Impact factor: 5.705

4.  Chest CT combined with artificial pneumothorax: value in determining origin and extent of tumor.

Authors:  A Watanabe; K Shimokata; H Saka; F Nomura; S Sakai
Journal:  AJR Am J Roentgenol       Date:  1991-04       Impact factor: 3.959

5.  Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging.

Authors:  S Shiotani; K Sugimura; M Sugihara; H Kawamitsu; M Yamauchi; M Yoshida; T Kushima; T Kinoshita; H Endoh; H Nakayama; M Kajitani; M Wada
Journal:  Radiat Med       Date:  2000 Sep-Oct

6.  Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

Authors:  Gerard A Silvestri; Michael K Gould; Mitchell L Margolis; Lynn T Tanoue; Douglas McCrory; Eric Toloza; Frank Detterbeck
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

7.  Ultrasound vs. CT in detecting chest wall invasion by tumor: a prospective study.

Authors:  Venkata Bandi; William Lunn; Armin Ernst; Ralf Eberhardt; Hans Hoffmann; Felix J F Herth
Journal:  Chest       Date:  2007-10-20       Impact factor: 9.410

Review 8.  Computed tomography-detected noncalcified pulmonary nodules: a review of evidence for significance and management.

Authors:  Annette McWilliams; John Mayo
Journal:  Proc Am Thorac Soc       Date:  2008-12-15

Review 9.  The role of positron emission tomography in the management of non-small cell lung cancer.

Authors:  Abdollah Behzadi; Yee Ung; Val Lowe; Claude Deschamps
Journal:  Can J Surg       Date:  2009-06       Impact factor: 2.089

Review 10.  Integrated positron emission tomography/computed tomography fusion imaging: an emerging gold standard in lung cancer.

Authors:  S C Joshi; I Pant; F Hamzah; G Kumar; A N Shukla
Journal:  Indian J Cancer       Date:  2008 Oct-Dec       Impact factor: 1.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.